stars 1 stars 2 stars 3

Biofarma Group is the global player that develops, produces and packages food supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties. Including 4 production sites in Italy (Friuli Venezia Giulia - HQ, Veneto and Lombardy), 2 production sites in France, 1 in the USA and 1 in China, Biofarma Group offers customized solutions and a comprehensive service, from the development of the idea to the finished product. The Company offers to customers a broad catalogue of products ready for distribution, some of them with clinical studies, and medical devices available in out-licensing including dossiers, some of them patented, with the possibility of being marketed all over the world. Innovation, competence and excellence are the values that, combined with investments in production processes, cutting-edge machinery and human capital, allow the Group to represent, globally, a highly attractive and competitive landmark in the development and manufacture of Health-Care and Beauty Care products.

Biofarma spa Questions

The Biofarma spa annual revenue was $494.8 million in 2026.

Alberto Urli is the CEO of Biofarma spa.

379 people are employed at Biofarma spa.

The NAICS codes for Biofarma spa are [3254, 32541, 32, 325].

The SIC codes for Biofarma spa are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users